Poland is not “one of the good options” or “an interesting emerging market," says Tomasz Szelag, head of clinical operations, Ryvu Therapeutics. Rather, it should be one of the first places sponsors look to run their clinical trials.
- Clinical Supply's Role In Driving Success In Decentralized Trials
- The 2020 Pediatric Mandate That Shook Up Oncology Research
- The Site Perspective: Why Ambient AI Is The Missing Link In Clinical Trial Data Integrity
- Why HEOR Keeps Arriving Too Late — And How ClinOps Can Fix It
- Overcoming Cell Therapy Design Challenges To Treat AML And Other Life-Threatening Diseases
- Takeda Keeps Patients The Focus Of PDTs For Rare Disease
- Designing Patient-Centric Recruitment Pathways With Real-Time Adherence Insights
GUEST COLUMNISTS
-
Designing Patient-Centric Recruitment Pathways With Real-Time Adherence Insights
Learn how digital adherence solutions can enable real-time monitoring and site-level oversight to improve patient engagement and protocol compliance.
-
Navigating The Challenges Of Cell Therapy Clinical Trials
IN8bio CEO William Ho shares how they overcame operational challenges unique to cell therapy research, including how to carefully conduct site expansion and onboard new sites without disrupting study timelines.
-
Patient Input Is A Must — Even Under Time And Money Constraints
Stacie J. Bell, PhD, chief clinical research officer of Lupus Therapeutics, discusses the positive impacts patient advocacy groups can have on patient recruitment, patient retention, protocol design, and more.
-
From Supercomputers To The Cloud: How Pharma's R&D Infrastructure Transformation Impacts Clinical Trials
Discover how pharma R&D is moving from traditional compute clusters to AI-driven HPC ecosystems and hybrid architectures that combine on-premise supercomputing with elastic cloud infrastructure.
-
Need An Investigator? There's An APP — Advanced Practice Provider — For That
Fewer available principal investigators (PIs) is not a new problem for clinical research, but it does necessitate some new and creative solutions. Learn how advanced practice providers (APPs) might help fill the PI gap.
-
Digital Biomarkers Are Reshaping Alzheimer's Patient Experience And Data
Cognito CEO Christian Howell shares how EEG and digital biomarkers are reshaping recruitment, patient experience, and the quality of study data in Alzheimer’s research.
-
An FDA First: Dompé Shares Experience Of Securing A Commissioner's National Priority Voucher
Dompé Chief Development Officer Ahmed Enayetallah reveals how the team earned the FDA's new Commissioner’s National Priority Voucher.
-
A Tale Of Two Sites: How FastWave Ran Trials In Distinct Locales
No two sites are the same. Discover how FastWave Medical chose its global sites, and learn best practices on who to partner with and how.
CLINICAL TRIAL WHITE PAPERS
-
Vaccine Clinical Trials Global Landscape Whitepaper (2024)
The global vaccine trial landscape is undergoing rapid evolution, driven by technological innovations, emerging health threats, and regulatory shifts.
-
Therapeutic Radiopharmaceuticals: Clinical Research, CRO Enablers (2025)11/7/2025
Accelerate the future of precision oncology by driving innovation, optimizing clinical development, and expanding access to targeted therapies that transform patient outcomes.
-
The True ROI Of Decentralized Clinical Trials11/13/2025
Gain a greater understanding of how the right DCT solution, or combination of solutions, coupled with clear metrics and expert guidance on execution, can demonstrate tangible, quantitative ROI in clinical trials.
-
Rewriting The Future Of Clinical Trials8/8/2025
In an increasingly data-complex environment, eCOA is emerging as a foundational pillar for both operational agility and scientific rigor in clinical development
-
Digital Endpoint Resource Guide: Obesity And Related Metabolic Disorders8/15/2024
Explore how digital health technologies can enhance obesity treatment by providing critical insights beyond weight loss.
-
Everest Group Life Sciences eCOA Peak Matrix Assessment 20259/16/2025
Discover how digital platforms are revolutionizing clinical trials by improving data quality and patient engagement in this comprehensive market assessment.
CLINICAL TRIAL APP NOTES & CASE STUDIES
-
Boosting Recruitment Strategy For Phase III Study In Ulcerative Colitis6/10/2025
Learn about the successful execution of a challenging three-arm, randomized, placebo-controlled Phase 3 study in Ulcerative Colitis despite strict inclusion criteria and a limited patient pool.
-
Redefining Accessibility For Pediatric Patients9/24/2025
Explore how meeting patients where they are can redefine what successful pediatric trial delivery looks like.
-
Elevating Diverse Patient Voices To Inspire Clinical Trial Participation1/9/2025
Explore the innovative approach taken during this clinical trial partnership to address the underrepresentation of minority communities in clinical trials through digital storytelling.
-
Using eConsent Data To Populate Site And Sponsor Data Systems10/7/2024
A top-10 pharmaceutical company was looking to reduce the amount of administrative burden on their clinical trial sites and themselves. See how we accomplished it, using eConsent.
-
Supporting A CAR T-Cell Therapy Study In Hematologic Malignancies3/24/2025
To address a life-threatening complication of immunotherapy in hematologic malignancies, a U.S. biotech company developed a novel compound.
-
Top Biotech Achieves Recruitment And Improves Compliance Across 30 Sites5/14/2024
Uncover how a biotechnology company experienced recruitment and compliance success after utilizing Longboat to provide training for every staff member at every trial site.
NEWSLETTER ARCHIVE
- 12.15.25 -- New Initiative Helps Researchers Enroll Healthy Volunteers In High Impact
- 12.13.25 -- Best Of November
- 12.12.25 -- FDA Vs. MHRA Vs. EMA: Differences In Externally Controlled Trials
- 12.11.25 -- FDA First: Dompé Secures a Commissioner's National Priority Voucher
- 12.10.25 -- What The FDA Says About Investigator Responsibilities In DCTs
RECRUITMENT AND DIVERSITY
This section includes some helpful resources regarding patient recruitment and diversity in clinical trials, including this link to the FDA's guidance on diversity action plans.
-
Discover how AI ambient listening has changed the way Mikel Daniels, DPM, MBA, and his team conduct clinical research at WeTreatFeet Podiatry.
-
Learn how digital adherence solutions can enable real-time monitoring and site-level oversight to improve patient engagement and protocol compliance.
-
Stacie J. Bell, PhD, chief clinical research officer of Lupus Therapeutics, discusses the positive impacts patient advocacy groups can have on patient recruitment, patient retention, protocol design, and more.
FOCUS ON PATIENTS
-
Discover how AI ambient listening has changed the way Mikel Daniels, DPM, MBA, and his team conduct clinical research at WeTreatFeet Podiatry.
-
Takeda’s Kristina Allikmets, MD, Ph.D, shares how her team incorporates patient voices and prioritizes innovations to reduce treatment burden, expand access, and develop plasma-derived therapies for rare diseases.
-
Learn how digital adherence solutions can enable real-time monitoring and site-level oversight to improve patient engagement and protocol compliance.